Unitedhealth Expected to Post Higher Profit Amid Rate Hikes

Dow Jones
07/16
 

UnitedHealth is scheduled to report its second-quarter financial results before the market opens on Thursday. Here is what to know.

REVENUE: The country's biggest health insurance company is expected to report $110.79 billion in sales, compared with $111.62 billion in the previous second quarter, according to FactSet.

NET PROFIT: The Eden Prairie, Minn.-based company is expected to post a profit of $4.17 billion, compared with a profit of $3.41 billion the year before, according to FactSet.

ADJUSTED EARNINGS PER SHARE: Adjusted earnings are expected to come in at $4.88 a share, compared with $4.08 a share the prior year.

The stock has gained 26% this year, and recently traded at $424.

WHAT TO WATCH

- UnitedHealth is undergoing several strategic initiatives that position it well for growth ahead, Truist analysts. The analysts see the company's $1.5 billion investment in artificial intelligence this year as a way to drive operational efficiency, reduced friction, interoperability and better consumer experience.

- Elevance Health, another major health insurer, reported on Wednesday that membership fell, particularly in its Affordable Care Act and Medicaid plans. The company is exiting several Medicaid markets as government health insurance costs rise. Elevance, UnitedHealth and other insurers have also been raising ACA rates and plan to continue to do so next year, The Wall Street Journal reported.

- UnitedHealth's rate hikes have also improved its positioning with ACA plans, while membership is expected to shrink by a third, the Truist analysts say. Medicaid margins are expected to stay negative this fiscal year, but the analysts think they will improve in 2027 and beyond. They also see Medicare expanding margins in 2026, and think UnitedHealth's margins will recover overall across government-sponsored programs.

 

Write to Katherine Hamilton at katherine.hamilton@wsj.com

 

(END) Dow Jones Newswires

July 15, 2026 12:18 ET (16:18 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10